OVERC
LIVE

Serial Number

79372086

Owner

Guangzhou Burning Rock Dx Co., Ltd.

Attorney

Jeffrey A. Smith

Filing Date

Mar 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

OVERC Trademark

Serial Number: 79372086 • Registration: 7554152

OVERC is a trademark filed by Guangzhou Burning Rock Dx Co., Ltd. on March 23, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Guangzhou Burning Rock Dx Co., Ltd. (8 trademarks)

Units 201-202, 2nd Floor, No. 7 Luoxuan 4th Road,

Entity Type: 99

Trademark Details

Filing Date

March 23, 2023

Registration Date

November 5, 2024

Published for Opposition

August 20, 2024

Goods & Services

Apparatus for DNA and RNA testing for medical purposes; medical diagnostic apparatus for testing cancer cells and DNA; medical apparatus for detecting cancer; apparatus for use in medical analysis, namely, apparatus for analyzing and identifying cancer cells; apparatus for use in medical analysis, namely, body composition analyzers for medical purposes; electrical stimulation apparatus for nerves, muscles, skin for physical therapy, rehabilitative and pain management purposes; galvanic apparatus for therapeutic purposes, namely, electrotherapy devices for providing transcutaneous electrical nerve stimulation, infrared heat and compression

Data processing apparatus; computer programs, recorded for use with diagnostic devices and testing kits to profile and detect mutations, genetic predispositions and other biomarkers related to the presence of cancer; downloadable computer application software for mobile phones, namely, software for use with diagnostic devices and testing kits to profile and detect mutations, genetic predispositions and other biomarkers related to the presence of cancer; computer software, recorded for use with diagnostic devices and testing kits to profile and detect mutations, genetic predispositions and other biomarkers related to the presence of cancer; computer software applications, downloadable for use with diagnostic devices and testing kits to profile and detect mutations, genetic predispositions and other biomarkers related to the presence of cancer; biometric scanners; electronic agendas; scales; surveying apparatus and instruments; devices in the nature of medical laboratory research instruments for analyzing genome information; diagnostic apparatus for detecting free dna in cancer cells for laboratory or research use, not for medical purposes; diagnostic apparatus for detecting genetic sequences for laboratory or research use, not for medical purposes; laboratory robots; test tubes; optical inspection apparatus

Research and development of new products for others; technological research in the field of medical instruments; scientific laboratory services; product quality testing; chemical analysis; medical and scientific research, namely, conducting clinical trials for others; genetic screening testing, for the purpose of scientific research; structural and functional analysis of genomes; genetic testing for scientific research purposes; blood analysis services; pharmaceutical product evaluation; medical laboratory services; DNA screening for scientific research purposes; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; cloud computing featuring software for use in database management, for use as a spreadsheet, for word processing; software as a service (SaaS) services featuring software for use with diagnostic devices and testing kits for detecting mutations, genetic predispositions and other biomarkers related to the presence of cancer; computer programming

Advertising services; organization of exhibitions for commercial or advertising purposes; marketing services; personnel recruitment; systemization of information into computer databases; compilation of information into computer databases; updating and maintenance of data in computer databases; business administrative services for medical referrals; sponsorship search

Biological preparations for medical purposes, namely, biological preparations for detecting genetic predispositions for medical purposes; biological preparations for medical purposes, namely, biological preparations for detecting the presence of cancer through blood and body fluid testing; reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; chemical preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes; dietetic substances adapted for medical use, namely, dietetic preparations adapted for medical purposes; dietetic foods and beverages adapted for medical use; diagnostic preparations for veterinary purposes; tissues impregnated with pharmaceutical lotions for use in detecting cancer; tissues impregnated with pharmaceutical lotions for use in blood collection

Medical assistance; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; telemedicine services; medical equipment rental; health counselling; medical screening; genetic testing for medical purposes; collection and preservation of human blood; beauty salon services; veterinary services; gardening; rental of sanitary installations

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 5, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 5, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 20, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 31, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 10, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 10, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 10, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 10, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 2, 2024 TROA
REFUSAL PROCESSED BY IB
Jan 31, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 9, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jan 9, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 27, 2023 RFCR
NON-FINAL ACTION WRITTEN
Dec 26, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 19, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 18, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 12, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 6, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 15, 2023 REPR